Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

NCT06064851 is registered in ClinicalTrials.gov with Five Liters, Inc. as lead sponsor.

NCT NCT06064851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06064851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease
Lead sponsor
Five Liters, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 27, 2023
Completion date
April 18, 2025
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding, von willebrand disease, type 1